<DOC>
	<DOCNO>NCT01673282</DOCNO>
	<brief_summary>This observational study aim investigate VIMPAT® use adjunctive therapy clinical practice also evaluate subsequent change drug load patient addition VIMPAT® treatment regimen .</brief_summary>
	<brief_title>Study Evaluating Changes Total Drug Load Seizure Frequency Using Vimpat® ( Lacosamide ) Combination Therapy</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>The patient receive Vimpat® 7 day prior start NonInterventional Study ( NIS ) The patient must diagnosis epilepsy partialonset seizure without secondary generalization Based physician 's clinical judgment , patient 's best interest prescribe adjunctive Vimpat® ( ie , decision prescribe Vimpat® make physician ) Patient must least 18 year age The patient must least one seizure within last 3 month prior enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lacosamide</keyword>
	<keyword>Vimpat</keyword>
	<keyword>Focal Epilepsy</keyword>
	<keyword>Drug Load</keyword>
	<keyword>AED</keyword>
	<keyword>SP1065</keyword>
</DOC>